粪便提取系统市场份额，规模，趋势，行业分析报告，按测定（CalProtectin，白蛋白，血红蛋白，胆汁酸，其他）;征兆;通过分析测试;结束使用;按地区;分部预测，2022 - 2030

Report Summary

The global faecal extraction systems market was valued at USD 1.60 billion in 2021 and is expected to grow at a CAGR of 3.6% during the forecast period. A faecal extraction system is a device/tool that is utilized for the collection of stool samples for the detection of different kinds of viruses, bacteria, or any other type of parasitic particle present in the stool.

Know more about this report:request for sample pages

粪便中任何寄生虫的阳性鉴定显示患者身体中感染的存在。预计IBD（炎症肠疾病）的普及越来越多的患病率促进了粪便提取​​系统市场的增长。根据CDC（疾病控制和预防中心），美国IBD患者的住院率增加，2018年的44.2％至59.7％，由于这一疾病的影响超过300万人。

然而，预计产品的高成本是为了阻碍粪便提取系统市场的增长。Covid-19的发作反映了大便提取系统市场增长的垮台，因为由于对移动的失败，以及个人和商业活动的中断。期望供应链，锁定措施和有限的消费支出中断，以妨碍粪便提取系统行业的增长。

Covid-19爆发的影响深远，对全球各地的个人，社区和社团产生负面影响。患有慢性健康状况的人更具危险的危险性和体验Covid-19的并发症。越来越多地对Covid-19发育疫苗的投资，随着越来越多的患者治疗的支出，预计将妨碍对粪便提取系统市场的投资。

由于爆发，研究和学术机构延误或停止了在这一领域的研究活动。此外，预计企业支出和政府支持的下降将妨碍未来几年粪便提取系统行业的增长。然而，预计粪便提取系统市场预计会以快速的Covid恢复。

行业动态

成长司机
负责行业增长的主要因素是IBD的普遍性。另外，萃取系统获得的粪便样品有助于鉴定导致营养吸收不良的肠道感染和其他疾病。正确使用粪便提取系统有助于减少对不方便和耗时的其他相关诊断测试的需求。

These factors are anticipated to significantly drive the growth of the stool extraction systems industry. Furthermore, according to the Australian Critical Care Journal 2021, there is a link between incontinence-related dermatitis and a faecal extraction system that is connected to low negative pressure suction equipment. Anal pouches with low negative pressure suction are efficient in collecting faecal samples from severely ill individuals with faecal incontinence.

This study is anticipated to help the future development of better faecal collection methods that reduce the danger of post-collection skin inflammation and overall pain. This link between faecal collection systems and IAD (Incontinence associated dermatitis) is anticipated to offer lucrative stool extraction systems industry growth opportunities. Moreover, the diverse applications of a single sample are propelling the industry growth as the faecal sample can be examined from several angles, including microbiological, microscopic, and others.

报告细分

The market is primarily segmented on the basis of assay, indication, analysis test, end-use, and region.

By Assay	By Indication	By Analysis Test	By End-Use	By Region
calprotectin 白蛋白 血红蛋白 Bile Acids 其他	寄生感染 病毒感染 细菌迹象 营养不良吸收	Microscopic Chemical 免疫学 微生物学	Diagnostic Centers Hospitals & Clinics 守护诊所 研究中心	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) 拉丁美洲(Brazil, Mexico, Argentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report:request for sample pages

Insight by Assay

The Calprotectin segment is recorded to hold the larger shares in 2020 and is expected to lead the market in the forecasting years. The huge share of the segment can be attributed to the increasing number of IBD globally. According to the Morbidity and Mortality Report 2021, the prevalence of IBD in older adults has increased significantly over the past decade.

从2001年到2019年，克罗恩病病例的数量增加了3.4％，而溃疡性结肠炎每年增加2.8％。溃疡性结肠炎和克罗恩病来自IBS（炎症肠综合征）的甘蓝样品中CalProtectin水平的变化有助于鉴定可能导致问题的疾病。

血红蛋白部分预计旨在见证预测年度的最高增长率。该段的生长可归因于SBD（显着的肠疾病）的患病率，例如CRC（结直肠癌），HRA（较高风险腺瘤）和IBD。F-HB> 10微克HB / G粪便的结果定义为正。此外，血红蛋白试验有助于指导直肠出血患者的调查，并进一步使医生采取更好的实用方法。

地理概述

North America accounted for the largest revenue share in the global market in 2021. The huge share of the market in North America can be attributed to the presence of key market players coupled with the rising number of recent developments made by these companies. For instance, in March 2018, Werfen got clearance by US FDA (Food & Drug Administration) for their proprietary faecal extraction systems.

Additionally, ALPCO, one of the leading faecal extraction systems manufacturers, received the US FDA 510(k) clearance for their Calprotectin ELISA. Development such as these showcases the encouragement offered by government bodies for the development of novel systems, aiding the growth of the market. Moreover, the Europe drainage bottle market is anticipated to exhibit the highest CAGR over the forecasting years. The rising research and development activities are anticipated to boost the growth of the stool extraction systems market. The growing research on the development of new products with the help of product testing among the masses is on the rise in Europe.

For instance, Buehlmann, in partnership with Telia (developers of e-health platform), developed a telehealth system for IBD. Offering services such as comprehensive IBD patient monitoring coupled with continuous communication with healthcare professionals, providing them with the status of their test and others. Technological developments such as these are anticipated to drive the growth of the market.

Competitive Insight

一些主要的players operating in the global market include ALPCO, Alpha Laboratories, Arbor Assays, bioMérieux, BÜHLMANN, Calpro AS (Svar Lifescience), Cancax Biotech, DRG INSTRUMENTS GMBH, Promega Corporation, and Werfen.

粪便提取系统市场报告范围

Report Attributes	Details
Market size value in 2021	USD 1.60 billion
2030年收入预测	21.19亿美元
CANG.	3.6% from 2022 - 2030
基准	2021.
历史数据	2018年 - 2020年
Forecast period	2022 - 2030年
Quantitative units	Revenue in USD million/billion and CAGR from 2022 to 2030
持续的段	By Assay, By Indication, By Analysis Test, By End-Use, By Region
区域范围	North America, Europe, Asia Pacific, Latin America, Middle East & Africa
主要公司	Alpco，Alpha Laboratories，Arbor Assays，Biomérieux，Bühlmann，Calpro As（Svar LifeScience），Cancax Biotech，DRG Instruments GmbH，Promega Corporation和Werfen。